{
  "trial_id": "NCT00377520",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, race, ethnicity, ECOG performance status, prior chemotherapy regimens, measurable disease status, serum pregnancy test results, use of contraception, NSAID use, folic acid supplementation, dexamethasone use, vitamin B12 supplementation, prior radiation therapy.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Prior Treatment",
          "prior chemotherapy regimens"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "Grade (Histology)",
        "Gynecologic Oncology Group (GOG) Performance Status"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "ECOG performance status",
        "measurable disease status",
        "serum pregnancy test results",
        "use of contraception",
        "NSAID use",
        "folic acid supplementation",
        "dexamethasone use",
        "vitamin B12 supplementation",
        "prior radiation therapy."
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, ECOG performance status, prior chemotherapy regimens, measurable disease status, serum pregnancy test results, use of contraception, NSAID use, folic acid supplementation, dexamethasone use, vitamin B12 supplementation, prior radiation therapy."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Race/Ethnicity, Customized, Region of Enrollment, Prior Chemotherapy Regimen, Measurable Disease, Baseline Tumor Size, Performance Status, Hemoglobin Level, White Blood Cell Count, Platelet Count, Serum Creatinine, Liver Function Tests,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Prior Treatment",
          "Prior Chemotherapy Regimen"
        ],
        [
          "Gynecologic Oncology Group (GOG) Performance Status",
          "Performance Status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Grade (Histology)"
      ],
      "remaining_candidate_features": [
        "Measurable Disease",
        "Baseline Tumor Size",
        "Hemoglobin Level",
        "White Blood Cell Count",
        "Platelet Count",
        "Serum Creatinine",
        "Liver Function Tests"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Race/Ethnicity, Region of Enrollment, Prior Chemotherapy Regimen, Measurable Disease, Baseline Tumor Size, Performance Status, Hemoglobin Level, White Blood Cell Count, Platelet Count, Serum Creatinine, Liver Function Tests"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Histologic subtype of endometrial cancer, Performance status, Prior chemotherapy regimens, Prior radiation therapy, Measurable disease, Serum CA-125 level,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Grade (Histology)",
          "Histologic subtype of endometrial cancer"
        ],
        [
          "Gynecologic Oncology Group (GOG) Performance Status",
          "Performance status"
        ],
        [
          "Prior Treatment",
          "Prior chemotherapy regimens"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race/Ethnicity",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "Prior radiation therapy",
        "Measurable disease",
        "Serum CA-125 level"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Histologic subtype of endometrial cancer, Performance status, Prior chemotherapy regimens, Prior radiation therapy, Measurable disease, Serum CA-125 level"
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, performance status, histological subtype of endometrial cancer, prior chemotherapy regimens, prior radiation therapy, number of prior treatment regimens, time since last treatment, presence of measurable disease, serum CA-125 levels, hemoglobin levels, platelet count, white blood cell count, creatinine clearance, liver function tests, presence of comorbidities.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Gynecologic Oncology Group (GOG) Performance Status",
          "performance status"
        ],
        [
          "Grade (Histology)",
          "histological subtype of endometrial cancer"
        ],
        [
          "Prior Treatment",
          "prior chemotherapy regimens"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "prior radiation therapy",
        "number of prior treatment regimens",
        "time since last treatment",
        "presence of measurable disease",
        "serum CA-125 levels",
        "hemoglobin levels",
        "platelet count",
        "white blood cell count",
        "creatinine clearance",
        "liver function tests",
        "presence of comorbidities"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, performance status, histological subtype of endometrial cancer, prior chemotherapy regimens, prior radiation therapy, number of prior treatment regimens, time since last treatment, presence of measurable disease, serum CA-125 levels, hemoglobin levels, platelet count, white blood cell count, creatinine clearance, liver function tests, presence of comorbidities."
  }
}